Safety and Effectiveness of L2-7001 (Interleukin-2) in HIV-Positive Patients Receiving Anti-HIV Therapy
Public ClinicalTrials.gov record NCT00002449. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Bridging Dose-Escalation Study of the Safety, Pharmacokinetic Properties, and Immunologic Effect of Subcutaneous L2-7001 (Recombinant Human Interleukin-2) in Patients Infected With HIV With CD4+ T-Cell Counts of 300 to 500 Cells/mm3 and Viral Burden Under 10,000 Copies/Ml on Active Antiretroviral Therapy (ART)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to see if it is safe and effective to give HIV-positive patients L2-7001 (a type of interleukin-2) plus anti-HIV therapy. Interleukin-2 (IL-2) is a substance naturally produced by the body's white blood cells that plays an important role in helping the body fight infection. IL-2 may be able to boost the immune systems of people with HIV infection.
Study identification
- NCT ID
- NCT00002449
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 212 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 1999 (Type not available)
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jun 24, 2005
Started 1999
United States locations
- U.S. sites
- 23
- U.S. states
- 14
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sorra Research Ctr / Med Forum | Birmingham | Alabama | 35203 | — |
| Pacific Oaks Research | Beverly Hills | California | 90211 | — |
| Orange County Ctr for Special Immunology | Fountain Valley | California | 92708 | — |
| St Lukes Medical Group | San Diego | California | 92101 | — |
| Kaiser Foundation Hospital | San Francisco | California | 94118 | — |
| Denver Inf Disease Consultants | Denver | Colorado | 80220 | — |
| Dupont Circle Physicians Group | Washington D.C. | District of Columbia | 200091104 | — |
| Community AIDS Resource Inc | Coral Gables | Florida | 33146 | — |
| Steinhart Medical Associates | Miami | Florida | 33133 | — |
| Specialty Med Care Ctrs of South Florida Inc | Miami | Florida | 33142 | — |
| AIDS Research Alliance - Chicago | Chicago | Illinois | 60657 | — |
| Northstar Med Clinic | Chicago | Illinois | 60657 | — |
| Fenway Community Health Ctr | Boston | Massachusetts | 02115 | — |
| North Jersey Community Research Initiative | Newark | New Jersey | 071032842 | — |
| Albany Med College | Albany | New York | 12208 | — |
| Anderson Clinical Research Inc | Rego Park | New York | 11374 | — |
| Associates in Med and Mental Health | Tulsa | Oklahoma | 74114 | — |
| Research and Education Group | Portland | Oregon | 97210 | — |
| Anderson Clinical Research | Pittsburgh | Pennsylvania | 15221 | — |
| Central Texas Clinical Research | Austin | Texas | 78705 | — |
| N Texas Ctr for AIDS & Clin Rsch | Dallas | Texas | 75219 | — |
| Gathe, Joseph, M.D. | Houston | Texas | 77004 | — |
| Virginia Mason Med Ctr | Seattle | Washington | 98101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00002449, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 24, 2005 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00002449 live on ClinicalTrials.gov.